These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34161799)

  • 1. Mother-to-child transmission of HIV-1 and infant mortality in the first six months of life, in the era of Option B Plus combination antiretroviral therapy.
    Zijenah LS; Bandason T; Bara W; Chipiti MM; Katzenstein DA
    Int J Infect Dis; 2021 Aug; 109():92-98. PubMed ID: 34161799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Option B
    Zijenah LS; Bandason T; Bara W; Chipiti MM; Katzenstein DA
    AIDS Patient Care STDS; 2022 Apr; 36(4):145-152. PubMed ID: 35438521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
    Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
    Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia.
    Agabu A; Baughman AL; Fischer-Walker C; de Klerk M; Mutenda N; Rusberg F; Diergaardt D; Pentikainen N; Sawadogo S; Agolory S; Dinh TH
    PLoS One; 2020; 15(11):e0233341. PubMed ID: 33170840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of maternal ART on mother-to-child transmission (MTCT) of HIV at six weeks postpartum in Rwanda.
    Mugwaneza P; Lyambabaje A; Umubyeyi A; Humuza J; Tsague L; Mwanyumba F; Mutabazi V; Nsanzimana S; Ribakare M; Irakoze A; Mutaganzwa E; Lombard C; Jackson D
    BMC Public Health; 2018 Nov; 18(1):1248. PubMed ID: 30419870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of WHO recommendation for continued breastfeeding and maternal cART for prevention of perinatal and postnatal HIV transmission in Zambia.
    Ngoma MS; Misir A; Mutale W; Rampakakis E; Sampalis JS; Elong A; Chisele S; Mwale A; Mwansa JK; Mumba S; Chandwe M; Pilon R; Sandstrom P; Wu S; Yee K; Silverman MS
    J Int AIDS Soc; 2015; 18(1):19352. PubMed ID: 26140453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
    Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prompt HIV diagnosis and antiretroviral treatment in postpartum women is crucial for prevention of mother to child transmission during breastfeeding: Survey results in a high HIV prevalence community in southern Mozambique after the implementation of Option B.
    Fernández-Luis S; Fuente-Soro L; Nhampossa T; Lopez-Varela E; Augusto O; Nhacolo A; Vazquez O; Saura-Lázaro A; Guambe H; Tibana K; Ngeno B; Juga AJC; Cowan JG; Urso M; Naniche D
    PLoS One; 2022; 17(8):e0269835. PubMed ID: 35917332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe.
    Zijenah LS; Moulton LH; Iliff P; Nathoo K; Munjoma MW; Mutasa K; Malaba L; Zvandasara P; Ward BJ; Humphrey J;
    AIDS; 2004 Jan; 18(2):273-80. PubMed ID: 15075545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing mother to child transmission of HIV: lessons learned from China.
    Dong Y; Guo W; Gui X; Liu Y; Yan Y; Feng L; Liang K
    BMC Infect Dis; 2020 Oct; 20(1):792. PubMed ID: 33106179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
    Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
    AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 viremia during the first 28 weeks of pregnancy is not associated with mother-to-child transmission.
    Senise JF; Palacios R; Tanno ZN; Lunardi L; Waghabi GR; Vaz MJ; Diaz RS; Castelo A
    Braz J Infect Dis; 2006 Aug; 10(4):259-63. PubMed ID: 17293908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.